HomeNewsBusinessIndian Railways improves operating ratio to 97.45% in Covid-hit 2020-21

Indian Railways improves operating ratio to 97.45% in Covid-hit 2020-21

The improvement in the running costs of the Railways means the national transporter was able to lower its expenditure and make up for the shortfall in passenger traffic through revenue generated by freight operations.

June 27, 2021 / 17:47 IST
Story continues below Advertisement
Representative Image
Representative Image

Limited train services for most of the year with no subsidies or concessions and severely tightening of expenses have led to the Railways better its operating ratio to 97.45 per cent in the financial year 2020-21 from 98.36 per cent the previous fiscal, according to an RTI reply.

Operating ratio is the amount spent to earn every Rs 100. The lower it is the better. It is used to measure the operational efficiency of any organisation. Higher the operating ratio, lower the financial resources available for expansion and growth. The improvement in the running costs of the Railways means the national transporter was able to lower its expenditure and make up for the shortfall in passenger traffic through revenue generated by freight operations.

Story continues below Advertisement

Explained: How 4G spectrum will help Indian Railways and millions of passengers

"Operating ratio for the year 2019-2020 was 98.36 per cent… the operating ratio for 2020-21 has been calculated at 97.45 per cent on a provisional basis," the Railway Board said in reply to an RTI query by Madhya Pradesh-based activist Chandra Shekar Gaur. A railway spokesperson attributed the improved numbers to the strict monitoring of expenses by the national transporter which, he said, is a "combination of initiatives aimed at maximizing revenue receipts and minimizing controllable revenue expenses".

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show